• Nov 1, 2025 her 2 the making of herceptin a revolutionary trea al Trials and FDA Approval The pivotal clinical trials demonstrated that adding Herceptin to standard chemotherapy significantly improved survival rates in HER2-positive breast cancer patients. In 1998, the U.S. Fo By Justina Stoltenberg Sr.
